EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy

BACKGROUND: Epidermal growth factor (EGF) and its receptor (EGFR) are part of an important signaling pathway that is involved in the pathogenesis of squamous cell carcinoma of the head and neck (SCCHN). We hypothesized that EGF/EGFR genetic polymorphisms might have a prognostic impact on disease-fre...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Onco Targets Ther
Päätekijät: Su, Nai-Wen, Leu, Yi-Shing, Lee, Jehn-Chuan, Liu, Chung-Ji, Cheng, Chieh-Yuan, Lin, Jiun-Sheng, Chen, Yu-Jen, Chen, Chi-Kuan, Fang, I-Chih, Hsieh, Ruey-Kuen, Chang, Yi-Fang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2014
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259259/
https://ncbi.nlm.nih.gov/pubmed/25506224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S70188
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia